A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas

Genes Chromosomes and Cancer

Volumn 53, Issue 5, 2014, Pages 392-401

  Gao, Ge ^a   Kasperbauer, Jan L ^a   Tombers, Nicole M ^a   Wang, Vivian ^a   Mayer, Kevin ^a   Smith, David I ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CTNNA 3 PROTEIN; DLG 2 PROTEIN; DMD PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; NBEA PROTEIN; PARK 2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; MIDDLE AGED; MULTIPLE CANCER; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; TUMOR SUPPRESSOR GENE; UPREGULATION; VERY ELDERLY;

HUMAN PAPILLOMAVIRUS;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; AGED, 80 AND OVER; ALPHA CATENIN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CHROMOSOME FRAGILE SITES; DYSTROPHIN; FEMALE; GUANYLATE KINASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OROPHARYNX; PAPILLOMAVIRIDAE; PHARYNGEAL NEOPLASMS; SEQUENCE ANALYSIS, RNA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84895929884     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22150     Document Type: Article

References (49)

1. Accardi R, Rubino R, Scalise M, Gheit T, Shahzad N, Thomas M, Banks L, Indiveri C, Sylla BS, Cardone RA, Reshkin SJ, Tommasino M. 2011. E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1. J Virol 85:8208-8216.
2. Becker NA, Thorland EC, Denison SR, Philips LA, Smith DI. 2002. Evidence that instability within the FRA3B region extends four metgabases. Oncogene 21:8713-8722.
3. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. 2000. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23-24.1, a region frequently affected in breast cancer. Cancer Res 60:2140-2145.
4. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. 2001. WWOW, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068-8073.
5. Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, Bensimon A, Zamir G, Shewach DS, Kerem B. 2011. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145:435-446.
6. Bosco N, Pelliccia F, Rocchi A. 2010. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region. Cancer Genet Cytogenet 202:47-52.
7. Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI. 2003. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22:590-601.
8. Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CM. 2003. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci USA 100:5956-5961.
9. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. 2011. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294-4301.
10. Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI. 2003. Characterization of FRA6E and its potential role in autosomal recessive juvenlile parkinsonism and ovarian cancer. Genes Chromosomes Cancer 38:40-52.
11. Ding D, Lou X, Hua D, Yi W, Li L, Wang J, Gao F, Zhao N, Ren G, Li L, Lin B. 2012. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet 8:e1003065.
12. Duensing S, Munger K. 2002. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62:7075-7082.
13. Dumon KR, Ishii H, Fong LY, Zanesi N, Fidanza V, Mancini R, Vecchione A, Baffa R, Trapasso F, During MJ, Huebner K, Croce CM. 2001. FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci USA 98:3346-3351.
14. Fabbri M, Iliopoulos D, Trapasso F, Aqeilan RI, Cimmino A, Zanesi N, Yendamuri S, Han SY, Amadori D, Huebner K, Croce CM. 2005. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci USA 102:15611-15616.
15. Fanjul-Fernández M, Quesada V, Cabanillas R, Cadiñanos J, Fontanil T, Obaya A, Ramsay AJ, Llorente JL, Astudillo A, Cal S, López-Otín C. 2013. Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas. Nat Commun 4:2531.
16. Gao G, Chernock RD, Gay HA, Thorstad WL, Zhang TR, Wang H, Ma XJ, Luo Y, Lewis JS, Jr., Wang X. 2013. A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer 132:882-890.
17. Gao G, Johnson SH, Kasperbauer JL, Eckloff BW, Tombers NM, Vasmatizis G, Smith DI. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer. J Clin Virol, 2013 Epub S1386-6532(13)00537-4.
18. Glover TW, Berger C, Coyle J, Echo B. 1984. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:136-142.
19. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. 2010. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: A high-density single nucleotide polymorphism array analysis. Cancer Prev Res 3:1176-1186.
20. Helmrich A, Ballarino M, Tora L. 2011. Collisions between replication and transcription complexes causes common fragile site instability at the longest human genes. Mol Cell 44:966-977.
21. International Human Genome Sequencing Consortium. 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-945.
22. Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI. 2000. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics 69:37-46.
23. Laborde RR, Wang VW, Smith TM, Olson NE, Olsen SM, García JJ, Olsen KD, Moore EJ, Kasperbauer JL, Tombers NM, Smith DI. 2012. Transcriptional profiling by sequencing of oropharyngeal cancer. Mayo Clin Proc 87:226-232.
24. Lander ES, Linton LM, Birren B, Nussbaum C, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
25. Langbein S, Szakacs O, Wilhelm M, Sukosd F, Weber S, Jauch A, Lopez Beltran A, Alken P, Kalble T, Kovacs G. 2002. Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest 82:639-643.
26. Le Tallec B, Millot GA, Blin ME, Brison O, Dutrillaux B, Debatisse M. 2013. Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes. Cell Rep 4:420-428.
27. McAvoy S, Ganapathiraju S, Perez DS, James CD, Smith DI. 2007. DMD and IL1RAPL1: Two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors. Cytogenet Genome Res 119:196-203.
28. McAvoy S, Zhu Y, Perez DS, James CD, Smith DI. 2008. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers. Genes Chromosomes Cancer 47:165-174.
29. Meehan M, Melvin A, Gallagher E, Smith J, McGoldrick A, Moss C, Goossens S, Harrison M, Kay E, Fitzpatrick J, Dervan P, McCann A. 2007. Alpha-T-catenin (CTNNA3) displays tumor specific monoallelic expression in urothelial carcinoma of the bladder. Genes Chromsomes Cancer 46:587-593.
30. Mroz EA, Forastiere AA, Rocco JW. 2011. Implication of the oropharyngeal cancer epidemic. J Clin Oncol 29:4222-4223.
31. Nancarrow DJ, Handoko HY, Smithers BM, Gotley DC, Drew PA, Watson DI, Clouston AD, Hayward NK, Whiteman DC. 2008. Genome-wide copy number arrays in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res 68:4163-4172.
32. Ohta M, Inouse H:, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
33. O'Neal J, Gao F, Hassan A, Monahan R, Barrios S, Kilimann MW, Lee I, Chng WJ, Vij R, Tomasson MH. 2009. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma. Exp Hematol 37:234-244.
34. Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CM. 2004. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res 10:2720-2724.
35. Pichiorri F, Palumbo T, Suh SS, Okamura H, Trapasso F, Ishii H, Huebner K, Croce CM. 2008. Fhit tumor suppressor: guardian of the preneoplastic genome. Future Oncol 4:815-824.
36. Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, Luo F, Cantley LC, Wyllie AH, Adams DJ, Arends MJ. 2010. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci USA 107:15145-15150.
37. Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, Smith DI, Gollin SM. 2007. Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer 46:143-154.
38. Roberts S, Delury C, Marsh E. 2012. The PDZ protein discs-large (DLG): The 'Jekyll and Hyde' of the epithelial polarity proteins. FEBS J 279:3549-3558.
39. Rozier L, El-Achkar E, Apiou F, Debatisse M. 2004. Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: Possible association with an inherited disease and cancer. Oncogene 23:6872-6880.
40. Savelyeva L, Saqulenko E, Schmitt JG, Schwab M. 2006. The neuobeachin gene spans the common fragile site FRA13A. Hum Genet 118:551-558.
41. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K. 1997. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94:13771-13776.
42. Smith DI, Zhu Y, McAvoy S, Kuhn R. 2006. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 232:48-57.
43. Smith DI, McAvoy S, Zhu Y, Perez DS. 2007. Large common fragile site genes and cancer. Semin Cancer Biol 17:31-41.
44. Van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB. 2010. Oropharyngeal squamous cell carcinoma: A unique disease on the rise? Oral Oncol 46:780-785.
45. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Millinghoff IK, Solit DB, Chan TA. 2010. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 42:77-82.
46. Venter JC, Adams MD, Myers EW. Li PW, Mural RJ, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
47. Watanabe A, Hippo Y, Taniguchi H, Iwanari H, Yashiro M, Hirakawa K, Kodama T, Aburatani H. 2003. An opposing view on WWOX protein function as a tumor suppressor. Cancer Res 63:8629-8633.
48. Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, Rüdiger T, McCue PA, Croce CM, Huebner K. 2001. The tumor spectrum in FHIT-deficient mice. Proc Natl Sci USA 98:10250-10255.
49. Zhu Y, McAvoy S, Kuhn R, Smith D. 2006. RORA, a large common fragile site gene, is involved in cellular stress response. Oncogene 25:2901-2908.